Jones Financial Companies Lllp raised its stake in Cognex Corporation (NASDAQ:CGNX - Free Report) by 25,934.3% during the first quarter, according to its most recent disclosure with the SEC. The fund owned 34,886 shares of the scientific and technical instruments company's stock after buying an additional 34,752 shares during the quarter. Jones Financial Companies Lllp's holdings in Cognex were worth $1,041,000 as of its most recent SEC filing.
A number of other hedge funds also recently added to or reduced their stakes in CGNX. Farther Finance Advisors LLC raised its stake in shares of Cognex by 439.4% during the first quarter. Farther Finance Advisors LLC now owns 971 shares of the scientific and technical instruments company's stock valued at $29,000 after purchasing an additional 791 shares in the last quarter. GAMMA Investing LLC raised its stake in shares of Cognex by 155.3% during the first quarter. GAMMA Investing LLC now owns 1,062 shares of the scientific and technical instruments company's stock valued at $32,000 after purchasing an additional 646 shares in the last quarter. UMB Bank n.a. raised its stake in shares of Cognex by 105.5% during the first quarter. UMB Bank n.a. now owns 1,280 shares of the scientific and technical instruments company's stock valued at $38,000 after purchasing an additional 657 shares in the last quarter. Global X Japan Co. Ltd. bought a new stake in shares of Cognex during the first quarter valued at about $38,000. Finally, Caitong International Asset Management Co. Ltd raised its stake in shares of Cognex by 82.6% during the first quarter. Caitong International Asset Management Co. Ltd now owns 1,749 shares of the scientific and technical instruments company's stock valued at $52,000 after purchasing an additional 791 shares in the last quarter. 88.12% of the stock is currently owned by institutional investors.
Cognex Stock Up 4.8%
NASDAQ CGNX traded up $2.11 during trading on Thursday, hitting $46.19. The company's stock had a trading volume of 3,678,894 shares, compared to its average volume of 1,776,273. The firm has a 50 day moving average price of $40.73 and a 200 day moving average price of $33.37. The firm has a market cap of $7.76 billion, a P/E ratio of 65.06 and a beta of 1.50. Cognex Corporation has a 52 week low of $22.67 and a 52 week high of $46.38.
Cognex (NASDAQ:CGNX - Get Free Report) last released its quarterly earnings data on Wednesday, July 30th. The scientific and technical instruments company reported $0.25 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.23 by $0.02. Cognex had a return on equity of 6.65% and a net margin of 13.13%.The business had revenue of $249.09 million for the quarter, compared to analysts' expectations of $246.70 million. During the same period in the previous year, the business posted $0.23 earnings per share. Cognex's quarterly revenue was up 4.2% on a year-over-year basis. Cognex has set its Q3 2025 guidance at 0.240-0.290 EPS. On average, equities analysts expect that Cognex Corporation will post 0.61 earnings per share for the current year.
Cognex Announces Dividend
The company also recently disclosed a quarterly dividend, which was paid on Thursday, August 28th. Investors of record on Thursday, August 14th were issued a dividend of $0.08 per share. The ex-dividend date was Thursday, August 14th. This represents a $0.32 dividend on an annualized basis and a dividend yield of 0.7%. Cognex's dividend payout ratio (DPR) is presently 45.07%.
Insider Activity
In other Cognex news, EVP Sheila Marie Dipalma sold 2,002 shares of the firm's stock in a transaction that occurred on Friday, September 5th. The stock was sold at an average price of $45.00, for a total value of $90,090.00. Following the completion of the transaction, the executive vice president directly owned 8,582 shares in the company, valued at $386,190. This trade represents a 18.92% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Insiders own 1.60% of the company's stock.
Analysts Set New Price Targets
A number of research analysts recently issued reports on the company. Needham & Company LLC lifted their target price on Cognex from $36.00 to $45.00 and gave the stock a "buy" rating in a report on Thursday, July 31st. Citigroup reaffirmed a "neutral" rating and set a $37.00 target price (up from $30.00) on shares of Cognex in a report on Monday, July 14th. UBS Group lifted their target price on Cognex from $53.00 to $58.00 and gave the stock a "buy" rating in a report on Friday, August 1st. Melius raised Cognex from a "hold" rating to a "buy" rating and set a $60.00 target price on the stock in a report on Thursday, July 10th. Finally, Robert W. Baird lifted their price target on Cognex from $30.00 to $32.00 and gave the stock a "neutral" rating in a research note on Monday, June 16th. One research analyst has rated the stock with a Strong Buy rating, seven have assigned a Buy rating, seven have issued a Hold rating and one has assigned a Sell rating to the company. According to MarketBeat.com, the stock presently has an average rating of "Moderate Buy" and a consensus price target of $43.07.
Get Our Latest Stock Report on Cognex
Cognex Company Profile
(
Free Report)
Cognex Corporation provides machine vision products that capture and analyze visual information to automate manufacturing and distribution tasks worldwide. Its machine vision products are used to automate the manufacturing and tracking of discrete items, including mobile phones, electric vehicle batteries, and e-commerce packages by locating, identifying, inspecting, and measuring them during the manufacturing or distribution process.
Featured Stories

Before you consider Cognex, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Cognex wasn't on the list.
While Cognex currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Fall 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.